D-1330-2022 Class II Terminated
FDA drug recall D-1330-2022 was initiated by Strides Pharma Inc. on Jul 19, 2022 and is designated Class II. Reason for recall: Presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets The recall status is terminated (terminated Jun 21, 2023). Affected quantity: 1032 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- Aug 17, 2022
- Initiation Date
- Jul 19, 2022
- Termination Date
- Jun 21, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1032 bottles
Product Description
Prednisone Tablets USP, 20 mg, 100-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd., Bengaluru - 562106, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816, NDC 64380-785-06.
Reason for Recall
Presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets
Distribution Pattern
US Nationwide
Code Information
Lot #: 7248988B, Exp 9/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1330-2022
- openFDA file date
- Nov 3, 2026
- Loaded by RegDataLab
- Nov 4, 2026